{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T04:44:32Z","timestamp":1776746672380,"version":"3.51.2"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T00:00:00Z","timestamp":1580688000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T00:00:00Z","timestamp":1580688000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s10067-020-04966-z","type":"journal-article","created":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T00:05:18Z","timestamp":1580774718000},"page":"963-965","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Possible benefit of tadalafil cream for the treatment of Raynaud\u2019s phenomenon and digital ulcers in systemic sclerosis"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7939-7837","authenticated-orcid":false,"given":"Andreu","family":"Fern\u00e1ndez-Codina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikameh","family":"Kazem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet E.","family":"Pope","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,3]]},"reference":[{"key":"4966_CR1","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/ard.2007.072686","volume":"67","author":"SI Nihtyanova","year":"2008","unstructured":"Nihtyanova SI, Brough GM, Black CM, Denton CP (2008) Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis. Ann Rheum Dis 67:120\u2013123. https:\/\/doi.org\/10.1136\/ard.2007.072686","journal-title":"Ann Rheum Dis"},{"key":"4966_CR2","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1002\/art.40560","volume":"70","author":"A Fern\u00e1ndez-Codina","year":"2018","unstructured":"Fern\u00e1ndez-Codina A, Walker KM, Pope JE (2018) Treatment algorithms for systemic sclerosis according to experts. Arthritis Rheumatol 70:1820\u20131828. https:\/\/doi.org\/10.1002\/art.40560","journal-title":"Arthritis Rheumatol"},{"key":"4966_CR3","doi-asserted-by":"publisher","unstructured":"Fern\u00e1ndez-Codina A, Ca\u00f1as-Ruano E, Pope JE (2019) Management of Raynaud\u2019s phenomenon in systemic sclerosis\u2014a practical approach. J Scleroderma Relat Disord 239719831882395. https:\/\/doi.org\/10.1177\/2397198318823951","DOI":"10.1177\/2397198318823951"},{"key":"4966_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10067-019-04564-8","volume":"39","author":"J Blagojevic","year":"2020","unstructured":"Blagojevic J, Abignano G, Avouac J, Cometi L, Frerix M, Bellando-Randone S, Guiducci S, Bruni C, Huscher D, Jaeger VK, L\u00f3r\u00e1nd V, Maurer B, Nihtyanova S, Riemekasten G, Siegert E, Tarner IH, Vettori S, Walker UA, Czirj\u00e1k L, Denton CP, Distler O, Allanore Y, M\u00fcller-Ladner U, Moggi-Pignone A, Matucci-Cerinic M, del Galdo F, EUSTAR co-workers (2020) Use of vasoactive\/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study. Clin Rheumatol 39:27\u201336. https:\/\/doi.org\/10.1007\/s10067-019-04564-8","journal-title":"Clin Rheumatol"},{"key":"4966_CR5","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1136\/annrheumdis-2012-201536","volume":"72","author":"LK Hummers","year":"2013","unstructured":"Hummers LK, Dugowson CE, Dechow FJ, Wise RA, Gregory J, Michalek J, Yenokyan G, McGready J, Wigley FM (2013) A multi-centre, blinded, randomised, placebo-controlled, laboratory-based study of MQX-503, a novel topical gel formulation of nitroglycerine, in patients with Raynaud phenomenon. Ann Rheum Dis 72:1962\u20131967. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201536","journal-title":"Ann Rheum Dis"},{"key":"4966_CR6","first-page":"51","volume":"27","author":"G Fiori","year":"2009","unstructured":"Fiori G, Galluccio F, Braschi F, Amanzi L, Miniati I, Conforti ML, del Rosso A, Generini S, Candelieri A, Magonio A, Goretti R, Rasero L, Matucci-Cerinic M (2009) Vitamin E gel reduces time of healing of digital ulcers in systemic sclerosis. Clin Exp Rheumatol 27:51\u201354","journal-title":"Clin Exp Rheumatol"},{"key":"4966_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jaad.2017.08.018","volume":"78","author":"X Wortsman","year":"2018","unstructured":"Wortsman X, Del Barrio-D\u00edaz P, Meza-Romero R et al (2018) Nifedipine cream versus sildenafil cream for patients with secondary Raynaud phenomenon: a randomized, double-blind, controlled pilot study. J Am Acad Dermatol 78:189\u2013190. https:\/\/doi.org\/10.1016\/j.jaad.2017.08.018","journal-title":"J Am Acad Dermatol"},{"key":"4966_CR8","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1093\/rheumatology\/keq291","volume":"49","author":"PD Shenoy","year":"2010","unstructured":"Shenoy PD, Kumar S, Jha LK, Choudhary SK, Singh U, Misra R, Agarwal V (2010) Efficacy of tadalafil in secondary Raynaud\u2019s phenomenon resistant to vasodilator therapy: a double-blind randomized cross-over trial. Rheumatology (Oxford) 49:2420\u20132428. https:\/\/doi.org\/10.1093\/rheumatology\/keq291","journal-title":"Rheumatology (Oxford)"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-04966-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-020-04966-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-04966-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T02:28:59Z","timestamp":1612232939000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-020-04966-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,3]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["4966"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-04966-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,3]]},"assertion":[{"value":"17 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was from the University of Western Ontario ethics board and all patients signed informed consent to be enrolled in the registry.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"A.F.C. received salary support from the Scleroderma Society of Ontario and St. Joseph\u2019s Hospital Foundation, London, Ontario (Kay Eldson donor). A.F.C. received consulting fees from Actelion. M.K. has no conflicts of interest. J.E.P. received consulting fees from Actelion, Bayer, BMS, Pfizer, and Roche. Some of the topical tadalafil was received as samples from Delivra, Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}